B-intervention	0	7	Aerobic
I-intervention	8	11	and
I-intervention	12	22	resistance
I-intervention	23	31	exercise
O	32	40	improves
O	41	49	physical
O	50	57	fitness
O	57	58	,
O	59	63	bone
O	64	70	health
O	70	71	,
O	72	75	and
O	76	83	quality
O	84	86	of
O	87	91	life
O	92	94	in
B-eligibility	95	105	overweight
I-eligibility	106	109	and
I-eligibility	110	115	obese
I-eligibility	116	122	breast
I-eligibility	123	129	cancer
I-eligibility	130	139	survivors
O	139	140	:
O	141	142	a
O	143	153	randomized
O	154	164	controlled
O	165	170	trial
O	170	171	.

O	172	180	Exercise
O	181	183	is
O	184	186	an
O	187	196	effective
O	197	205	strategy
O	206	208	to
O	209	216	improve
O	217	224	quality
O	225	227	of
O	228	232	life
O	233	236	and
O	237	245	physical
O	246	253	fitness
O	254	256	in
O	257	263	breast
O	264	270	cancer
O	271	280	survivors
O	280	281	;
O	282	289	however
O	289	290	,
O	291	294	few
O	295	302	studies
O	303	307	have
O	308	315	focused
O	316	318	on
O	319	322	the
O	323	328	early
O	329	341	survivorship
O	342	348	period
O	348	349	,
O	350	360	minorities
O	360	361	,
O	362	372	physically
O	373	381	inactive
O	382	385	and
O	386	391	obese
O	392	397	women
O	397	398	,
O	399	401	or
O	402	408	tested
O	409	410	a
O	411	419	combined
O	420	428	exercise
O	429	436	program
O	437	440	and
O	441	449	measured
O	450	454	bone
O	455	461	health
O	461	462	.

O	463	467	Here
O	467	468	,
O	469	471	we
O	472	478	report
O	479	482	the
O	483	490	effects
O	491	493	of
O	494	495	a
O	496	498	16
O	498	499	-
O	499	503	week
O	504	511	aerobic
O	512	515	and
O	516	526	resistance
O	527	535	exercise
O	536	548	intervention
O	549	551	on
O	552	559	patient
O	559	560	-
O	560	568	reported
O	569	577	outcomes
O	577	578	,
O	579	587	physical
O	588	595	fitness
O	595	596	,
O	597	600	and
O	601	605	bone
O	606	612	health
O	613	615	in
O	616	626	ethnically
O	627	634	diverse
O	634	635	,
O	636	646	physically
O	647	655	inactive
O	655	656	,
O	657	667	overweight
O	668	670	or
O	671	676	obese
O	677	683	breast
O	684	690	cancer
O	691	700	survivors
O	700	701	.

B-total-participants	702	705	One
I-total-participants	706	713	hundred
B-eligibility	714	720	breast
I-eligibility	721	727	cancer
I-eligibility	728	737	survivors
I-eligibility	738	744	within
I-eligibility	745	746	6
I-eligibility	747	753	months
I-eligibility	754	756	of
I-eligibility	757	767	completing
I-eligibility	768	776	adjuvant
I-eligibility	777	786	treatment
O	787	791	were
O	792	800	assessed
O	801	803	at
O	804	812	baseline
O	812	813	,
O	814	818	post
O	818	819	-
O	819	831	intervention
O	831	832	,
O	833	836	and
O	837	838	3
O	838	839	-
O	839	844	month
O	845	851	follow
O	851	852	-
O	852	854	up
O	855	856	(
O	856	864	exercise
O	865	870	group
O	871	875	only
O	875	876	)
O	877	880	for
O	881	889	physical
O	890	897	fitness
O	897	898	,
O	899	903	bone
O	904	911	mineral
O	912	919	density
O	919	920	,
O	921	926	serum
O	927	941	concentrations
O	942	944	of
O	945	949	bone
O	950	960	biomarkers
O	960	961	,
O	962	965	and
O	966	973	quality
O	974	976	of
O	977	981	life
O	981	982	.

O	983	986	The
O	987	995	exercise
O	996	1008	intervention
O	1009	1018	consisted
O	1019	1021	of
O	1022	1030	moderate
O	1030	1031	-
O	1031	1039	vigorous
O	1040	1041	(
O	1041	1043	65
O	1043	1044	-
O	1044	1046	85
O	1046	1047	%
O	1048	1053	heart
O	1054	1058	rate
O	1059	1066	maximum
O	1066	1067	)
O	1068	1075	aerobic
O	1076	1079	and
O	1080	1090	resistance
O	1091	1099	exercise
O	1100	1106	thrice
O	1107	1113	weekly
O	1114	1117	for
O	1118	1120	16
O	1121	1126	weeks
O	1126	1127	.

O	1128	1139	Differences
O	1140	1142	in
O	1143	1147	mean
O	1148	1155	changes
O	1156	1159	for
O	1160	1168	outcomes
O	1169	1173	were
O	1174	1183	evaluated
O	1184	1189	using
O	1190	1195	mixed
O	1195	1196	-
O	1196	1201	model
O	1202	1210	repeated
O	1211	1218	measure
O	1219	1227	analysis
O	1227	1228	.

O	1229	1231	At
O	1232	1236	post
O	1236	1237	-
O	1237	1249	intervention
O	1249	1250	,
O	1251	1254	the
O	1255	1263	exercise
O	1264	1269	group
O	1270	1273	was
O	1274	1282	superior
O	1283	1285	to
B-control	1286	1291	usual
I-control	1292	1296	care
O	1297	1300	for
B-outcome	1301	1308	quality
I-outcome	1309	1311	of
I-outcome	1312	1316	life
O	1317	1318	(
O	1318	1325	between
O	1326	1331	group
O	1332	1342	difference
O	1342	1343	:
O	1344	1346	14
O	1346	1347	.
O	1347	1348	7
O	1348	1349	,
O	1350	1352	95
O	1352	1353	%
O	1354	1356	CI
O	1356	1357	:
O	1358	1360	18
O	1360	1361	.
O	1361	1362	2
O	1362	1363	,
O	1364	1365	9
O	1365	1366	.
O	1366	1367	7
O	1367	1368	;
O	1369	1370	p
O	1371	1372	<
O	1373	1374	0
O	1374	1375	.
O	1375	1378	001
O	1378	1379	)
O	1379	1380	,
B-outcome	1381	1388	fatigue
O	1389	1390	(
O	1390	1391	p
O	1392	1393	<
O	1394	1395	0
O	1395	1396	.
O	1396	1399	001
O	1399	1400	)
O	1400	1401	,
B-outcome	1402	1412	depression
O	1413	1414	(
O	1414	1415	p
O	1416	1417	<
O	1418	1419	0
O	1419	1420	.
O	1420	1423	001
O	1423	1424	)
O	1424	1425	,
B-outcome	1426	1435	estimated
I-outcome	1436	1442	VO2max
O	1443	1444	(
O	1444	1445	p
O	1446	1447	<
O	1448	1449	0
O	1449	1450	.
O	1450	1453	001
O	1453	1454	)
O	1454	1455	,
B-outcome	1456	1464	muscular
I-outcome	1465	1473	strength
O	1474	1475	(
O	1475	1476	p
O	1477	1478	<
O	1479	1480	0
O	1480	1481	.
O	1481	1484	001
O	1484	1485	)
O	1485	1486	,
B-outcome	1487	1498	osteocalcin
O	1499	1500	(
O	1500	1501	p
O	1502	1503	=
O	1504	1505	0
O	1505	1506	.
O	1506	1508	01
O	1508	1509	)
O	1509	1510	,
O	1511	1514	and
B-outcome	1515	1519	BSAP
O	1520	1521	(
O	1521	1522	p
O	1523	1524	=
O	1525	1526	0
O	1526	1527	.
O	1527	1530	001
O	1530	1531	)
O	1531	1532	.

O	1533	1535	At
O	1536	1537	3
O	1537	1538	-
O	1538	1543	month
O	1544	1550	follow
O	1550	1551	-
O	1551	1553	up
O	1553	1554	,
O	1555	1558	all
B-outcome	1559	1566	patient
I-outcome	1566	1567	-
I-outcome	1567	1575	reported
I-outcome	1576	1584	outcomes
I-outcome	1585	1588	and
I-outcome	1589	1597	physical
I-outcome	1598	1605	fitness
I-outcome	1606	1615	variables
O	1616	1624	remained
O	1625	1638	significantly
O	1639	1647	improved
O	1648	1656	compared
O	1657	1659	to
O	1660	1668	baseline
O	1669	1671	in
O	1672	1675	the
O	1676	1684	exercise
O	1685	1690	group
O	1691	1692	(
O	1692	1693	p
O	1694	1695	<
O	1696	1697	0
O	1697	1698	.
O	1698	1700	01
O	1700	1701	)
O	1701	1702	.

O	1703	1704	A
O	1705	1707	16
O	1707	1708	-
O	1708	1712	week
O	1713	1721	combined
O	1722	1729	aerobic
O	1730	1733	and
O	1734	1744	resistance
O	1745	1753	exercise
O	1754	1761	program
O	1762	1770	designed
O	1771	1773	to
O	1774	1781	address
O	1782	1791	metabolic
O	1792	1800	syndrome
O	1801	1803	in
O	1804	1814	ethnically
O	1814	1815	-
O	1815	1822	diverse
O	1823	1833	overweight
O	1834	1836	or
O	1837	1842	obese
O	1843	1849	breast
O	1850	1856	cancer
O	1857	1866	survivors
O	1867	1871	also
O	1872	1885	significantly
O	1886	1894	improved
B-outcome	1895	1902	quality
I-outcome	1903	1905	of
I-outcome	1906	1910	life
O	1911	1914	and
B-outcome	1915	1923	physical
I-outcome	1924	1931	fitness
O	1931	1932	.

O	1933	1936	Our
O	1937	1945	findings
O	1946	1953	further
O	1954	1961	support
O	1962	1965	the
O	1966	1975	inclusion
O	1976	1978	of
O	1979	1989	supervised
O	1990	1998	clinical
O	1999	2007	exercise
O	2008	2016	programs
O	2017	2021	into
O	2022	2028	breast
O	2029	2035	cancer
O	2036	2045	treatment
O	2046	2049	and
O	2050	2054	care
O	2054	2055	.

O	2056	2060	This
O	2061	2066	trial
O	2067	2069	is
O	2070	2080	registered
O	2081	2083	on
O	2084	2098	ClinicalTrials
O	2098	2099	.
O	2099	2102	gov
O	2102	2103	:
O	2104	2115	NCT01140282
O	2116	2118	as
O	2119	2121	of
O	2122	2126	June
O	2127	2128	9
O	2128	2129	,
O	2130	2134	2010
O	2134	2135	.
